Viewing Study NCT00580060


Ignite Creation Date: 2025-12-25 @ 2:07 AM
Ignite Modification Date: 2026-03-01 @ 1:26 PM
Study NCT ID: NCT00580060
Status: COMPLETED
Last Update Posted: 2011-06-10
First Post: 2007-12-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AJCC View
None stage View
None IIB View
None IIC View
None III View
None IV View
None Melanoma View
None HLA-A2+ View
None Vaccine View